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GlycolysisHuman mitochondrial complex I (CI) deﬁciency is associated with progressive neurological disorders. To
better understand the CI pathomechanism, we here studied how deletion of the CI gene NDUFS4 affects
cell metabolism. To this end we compared immortalized mouse embryonic ﬁbroblasts (MEFs) derived
from wildtype (wt) and whole-body NDUFS4 knockout (KO) mice. Mitochondria from KO cells lacked the
NDUFS4 protein and mitoplasts displayed virtually no CI activity, moderately reduced CII, CIII and CIV activ-
ities and normal citrate synthase and CV (FoF1-ATPase) activity. Native electrophoresis of KO cell mitochon-
drial fractions revealed two distinct CI subcomplexes of ~830 kDa (enzymatically inactive) and ~200 kDa
(active). The level of fully-assembled CII–CV was not affected by NDUFS4 gene deletion. KO cells exhibited
a moderately reduced maximal and routine O2 consumption, which was fully inhibited by acute application
of the CI inhibitor rotenone. The aberrant CI assembly and reduced O2 consumption in KO cells were fully
normalized by NDUFS4 gene complementation. Cellular [NAD+]/[NADH] ratio, lactate production and mito-
chondrial tetramethyl rhodamine methyl ester (TMRM) accumulation were slightly increased in KO cells. In
contrast, NDUFS4 gene deletion did not detectably alter [NADP+]/[NADPH] ratio, cellular glucose consump-
tion, the protein levels of hexokinases (I and II) and phosphorylated pyruvate dehydrogenase (P-PDH), total
cellular adenosine triphosphate (ATP) level, free cytosolic [ATP], cell growth rate, and reactive oxygen spe-
cies (ROS) levels. We conclude that the NDUFS4 subunit is of key importance in CI stabilization and that,
due to the metabolic properties of the immortalized MEFs, NDUFS4 gene deletion has only modest effects
at the live cell level. This article is part of a special issue entitled: 17th European Bioenergetics Conference
(EBEC 2012).
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria generate energy in the form of adenosine triphos-
phate (ATP) and play a crucial role in cell metabolism, signalplex I or NADH:ubiquinone ox-
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rights reserved.transduction and survival. Structurally, mitochondria consist of an
outer membrane (MOM) that envelops a highly folded inner mem-
brane (MIM). The latter surrounds the mitochondrial matrix com-
partment where many metabolic reactions take place [1]. Proper
mitochondrial functioning requires the presence of a sufﬁciently
large proton gradient across the MIM. This gradient is maintained
by the action of the electron transport chain (ETC), which consists
of 4 multi-subunit complexes [2]. The ﬁrst complex (CI) extracts elec-
trons from reduced nicotinamide adenin-dinucleotide (NADH) and
donates them to coenzyme Q (CoQ or ubiquinone), allowing their
transport to complex III (CIII). Also complex II (CII) donates electrons
to CoQ by liberating them from succinate. Next, electrons are trans-
ported by cytochrome-c (cyt-c) to complex IV (CIV) where they are
donated to molecular oxygen (O2) to form water (H2O). At CI, CIII
and CIV the energy released by the electron transport is used to
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ter generates an inwardly directed trans-MIM electrochemical proton
motive force (PMF), associated with an inside-negative mitochondrial
membrane potential (Δψ), and a chemical proton gradient (ΔpH).
The PMF-driven backﬂow of protons is used by the FoF1-ATPase
(CV) to drive mitochondrial ATP synthesis. Together, the ETC and
CV constitute the oxidative phosphorylation (OXPHOS) system [3].
Mitochondrial CI (or NADH:ubiquinone oxidoreductase; EC
1.6.5.3) consists of 45 different subunits and constitutes the largest
OXPHOS complex with a molecular weight of ~1000 kDa [2,4–7].
Seven of the CI subunits are encoded by the mitochondrial DNA
(mtDNA) and the remainder by nuclear DNA (nDNA). The CI catalytic
core consists of 14 evolutionary conserved “structural” subunits that,
in humans, are encoded by 7 nDNA (NDUFV1, NDUFV2, NDUFS1,
NDUFS2, NDUFS3, NDUFS7, NDUFS8) and the 7 mtDNA genes (ND1–
ND6 and ND4L; [2,8]). The remainder of CI consists of 31 nDNA-
encoded supernumerary (“accessory”) subunits, of which it is pre-
sumed that they do not directly participate in the catalytic action of
CI [2,9]. In vitro and live-cell experiments suggest that biogenesis of
CI involves the stepwise assembly of pre-assembled modules
[5,10–13]. This process is assisted by at least 4 assembly-factors
(NDUFAF1–NDUFAF4), CIII and CIV [2,6,7,14]. In humans, mutations
in mtDNA- and nDNA-encoded CI structural, assembly-factor and ac-
cessory genes are associated with isolated CI deﬁciency (OMIM
252010). Currently, such mutations have been described for all 7 mi-
tochondrial mtDNA-encoded genes, all 4 known assembly factors and
17 of the nDNA-encoded genes [2,7,15]. Mutations in nDNA-encoded
CI subunits are generally inherited in an autosomal recessive manner
and induce CI deﬁciency, which is associated with a range of progres-
sive neurological disorders, often characterized by an early onset and
short devastating course [16].
The NDUFS4 gene is one of the genes often mutated in isolated
human CI deﬁciency [17–24]. NDUFS4mutations are generally associ-
ated with Leigh syndrome (OMIM 256000), which is an early-onset
progressive neurodegenerative disorder with a characteristic neuro-
pathology. The latter consists of focal, bilateral lesions in one or
more areas of the central nervous system, including the brainstem,
thalamus, basal ganglia, cerebellum, and spinal cord [16]. The
NDUFS4 gene encodes the NDUFS4 subunit of CI (a.k.a. the “AQDQ”
subunit), an 18-kDa protein. Evidence has been provided that this
protein can be C-terminally phosphorylated by protein kinase A
(PKA) in a cAMP-dependent manner [23,24]. This phosphorylation
appears to be involved in mitochondrial import and maturation of
the NDUFS4 protein, exchange of damaged against native NDUFS4
protein in intact CI and regulation of CI activity.
Future drug testing and (mitigative) treatment requires a proper
understanding of the clinical pathomechanism of CI deﬁciency. To
this end, suited cell and animal models need to be developed and ex-
perimentally characterized. Recently, the ﬁrst whole-body knock-out
(KO) mouse model for isolated CI deﬁciency was presented [25]. To
create these KO animals, exon 2 of the NDUFS4 gene was deleted
(NDUFS4−/− mice). This exon encodes the last part of the mitochon-
drial targeting sequence (MTS) and the ﬁrst 17 amino acids of the
NDUFS4 protein. Excision of exon 2 produces a frameshift precluding
the synthesis of mature NDUFS4. Similar to human patients, KO ani-
mals displayed encephalomyopathy, retarded grow rate, lethargy,
loss of motor skills, blindness and a high lactate level [25]. Here we
studied the cell metabolic consequences of NDUFS4 gene deletion by
comparing immortalized mouse embryonic ﬁbroblasts (MEFs) from
wildtype (wt) and NDUFS4−/− mice. It was found that MEFs from
NDUFS4 knockout animals contain an active but destabilized complex
I and that NDUFS4 gene deletion triggers a slightly more glycolytic
cellular phenotype. Interestingly, NDUFS4 gene deletion was not asso-
ciated with increased ROS levels or detectable alterations in total and
free cytosolic ATP levels. In the light of these observations, we discuss
the suitability of immortalized cell systems and/or high-glucoseculture conditions to study the (patho)physiology of mitochondrial
(dys)function.
2. Materials and methods
2.1. Generation and culturing of immortalized mouse embryonic
ﬁbroblasts
Primary mouse embryonic ﬁbroblast (MEF) cultures were gener-
ated from individual E12.5–13.5 embryos isolated from the inter-
cross of heterozygous NDUFS4+/− mice [25]. In brief, embryos were
dissected and the head and the internal organs were removed. The
remaining tissue was minced and digested for 15 min with Trypsin-
EDTA. This procedure was repeated until the tissue was completely
in suspension. The suspension was seeded in a T75 ﬂask with
DMEMmedium (no. 10938, Invitrogen, Breda, The Netherlands), con-
taining 25 mM D-glucose and supplemented with L-glutamine (4 mM
ﬁnal concentration), 1 mM sodium pyruvate, 10% (v/v) Fetal Calf
Serum (FCS, Greiner Bio-one, Frickenhausen, Germany) and 0.1% (v/
v) Gentamycin (Invitrogen). The obtained cells were cultured in a hu-
midiﬁed atmosphere of 95% air and 5% CO2 at 37 °C, expanded for two
passages and genotyped using polymerase chain reaction (PCR) anal-
ysis and speciﬁc forward and reverse primers designed for the
NDUFS4 gene: 5′-AGCCTGTTCTCATACCTCGG-3′ (forward; ~1229 bp)
and 5′-TTGTGCTTACAGGTTCAAAGTGA-3′ (reverse;~429 bp). DNA
was isolated from MEFs using the easy-DNATM kit (Invitrogen),
according to the manufacturer's instructions. The PCR was performed
using a Phire hot start II DNA Polymerase kit (Finnzymes, Espoo, Fin-
land). The samples were heated at 98 °C (40 s). Subsequent annealing
and extension were carried out at 52 °C (10 s) and at 72 °C (1 min),
respectively. Next, 34 cycles were carried out at 98 °C (10 s). Final ex-
tension was performed at 72 °C (10 min) on a Peltier Thermal Cycler
(MJ Research PTC-200). Using the above strategy, primary MEF cell
lines were generated from two different wt (wt1, wt2) and two dif-
ferent knock-out (KO) animals (KO1, KO2). Primary cultures were
spontaneously immortalized using the 3T3 protocol [26] and grown
in the above DMEM medium.
2.2. Retroviral complementation of immortalized mouse embryonic
ﬁbroblasts
The cDNA for the NDUFS4 subunit of CI was obtained by PCR of
reverse-transcribed mRNA using oligonucleotide primer sequences
taken from public databases and Pfu Turbo DNA polymerase (Agilent
Technologies-Stratagene, Amstelveen, The Netherlands). Subse-
quently, the cDNA was subcloned in bacterial cloning vectors and
veriﬁed by DNA sequencing. The cDNA was used as template DNA
for a second round of PCR, in which appropriate restriction sites
and a 5′ Kozak sequence (GCCACCATG) were introduced by addition
of the respective DNA sequences to the primers. Subsequently, the
cDNA, prepared with a Kozak sequence via the PCR primer, was
cloned into retroviral expression vector pLZRS-ires-Zeo. For produc-
tion of helper-free recombinant retrovirus, amphotrophic Phoenix
ΦNX-A packaging cells [27–29] were grown in DMEM and trans-
fected with the pLZRS-hNDUFS4-ires-Zeo plasmid using Lipofecta-
mine 2000 (Invitrogen). Viral supernatants (3 ml) supplemented
with polybrene were added to NDUFS4 KO MEFs (see above), seeded
one day prior to infection at a density of 100,000/well in 6-well cul-
ture plates, and infection was allowed for 24 h. Afterward, medium
was replaced by a selection medium with Zeocin (Invitrogen), for
14 days. Using the above procedure, complemented stable cell lines
were generated from wt1, KO1 and KO2 cells in which the
NDUFS4–cDNA was retrovirally introduced (wt1+S4, KO1+S4,
KO2+S4). Similarly, additional control cell lines were generated by
retrovirally transfecting wt and KO MEFs with an “empty” virus
(wt1+e, KO1+e and KO2+e).
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Human skin ﬁbroblasts of a healthy individual (CT5120) and two
patients with isolated CI deﬁciency due to a mutation in the NDUFS4
gene (VPEEKH167/VEKSIstop: P5737 and R106X: P5260; [16]) were
cultured in HEPES-buffered (25 mM)medium 199 (M199; Invitrogen)
with Earle's salt, containing 5.5 mM D-glucose and 0.7 mM L-glutamine,
in a humidiﬁed atmosphere of 95% air and 5% CO2 at 37 °C. M199 was
supplemented with 10% (v/v) fetal calf serum, 100 IU/ml penicillin and
100 IU/ml streptomycin (Invitrogen). The patient cells were obtained
from children in whom an isolated deﬁciency (OMIM 252010) was con-
ﬁrmed in both muscle tissue and cultured skin ﬁbroblasts. Biopsies were
performed following informed parental consent and according to the rel-
evant Institutional Review Boards.
2.4. Enzyme activity measurement
Activity of mitochondrial enzymes was determined in isolated
mitoplasts (i.e. isolated mitochondria without their outer mem-
branes) as described previously [30].
2.5. Native gel electrophoresis
MEFs were harvested by trypsinization, washed twice with ice-
cold PBS and resuspended in ice-cold PBS (100 μl). To obtain a
mitochondria-enriched fraction, cells were incubated with 4 mg/ml
digitonin (Sigma-Aldrich, St. Louis, MO, USA) in a ﬁnal volume of
200 μl for 10 min on ice. Next, the cells were centrifuged (10 min,
10,000 g, 4 °C) and mitochondrial pellets were washed twice with
1 ml ice-cold PBS and stored overnight (−20°C). Pellets were solubi-
lized in 100 μl “ACBT buffer” containing 1.5 M aminocaproic acid
(Sigma) and 75 mM Bis-Tris (Sigma). To isolate mitochondrial
OXPHOS complexes 20 μl 10% (w/v) β-lauryl maltoside (Sigma) was
added and the solution was incubated for 10 min on ice. Following
centrifugation (30 min, 10,000 g, 4 °C), the protein concentration
was determined using a protein assay kit (Biorad laboratories, Hercu-
les, USA). For quantitative analysis the gels were loaded with exactly
20 μg of mitochondrial protein. BN-PAGE was performed using a na-
tive page TM 4–16% Bis-Tris Gel (Invitrogen). Blotting was performed
using an iBlot Gel Transfer Stacks PVDF with iBlot system (Invitro-
gen). Immunodetection was carried out by incubating the blots with
antibodies directed against the NDUFA9 subunit of CI (CI-39; Mitos-
ciences, Eugene, Oregon), the 70 kDa subunit of CII (CII-70, Invitro-
gen), the core2 subunit of CIII (CIII-core2; Mitosciences), subunit 2
of CIV (CIV-2; Mitosciences) and the α subunit of CV (CV-α; Mitos-
ciences). The secondary antibody consisted of IRDye 800CW Conju-
gated Goat Anti-mouse IgG (H+L), Highly Cross Adsorbed (Li-Cor,
Lincoln, USA), diluted 1:10,000. Fluorescence scanning was per-
formed using an Odyssey Imaging system (Li-Cor) and ﬂuorograms
were inverted for visualization purposes. For in-gel activity analysis
the gel was incubated overnight with 2 mM Tris/HCl, 0.1 mg/ml
NADH, 2.5 mg/ml nitro blue tetrazolium (NBT; Sigma) at 4 °C and
scanned.
2.6. SDS-PAGE analysis of NDUFS4 protein levels
For human skin ﬁbroblasts and MEFs, mitochondria were isolated
as described in the previous section. In case of mouse muscle,
mitochondria-enriched fractions were obtained as described previ-
ously [31]. SDS-PAGE was performed with 5–20% gradient gel using
20 μg of protein for each lane. Proteins were electrophoretically trans-
ferred to a PVDF membrane (Millipore, Amsterdam, The Netherlands)
using a transfer buffer containing 20% (v/v) methanol, 25 mM Tris–
HCl, 192 mM glycine and 0.02% (w/v) SDS. After blotting, membranes
were blocked for 1 h in Odyssey blocking buffer (Li-Cor) and PBS
(ratio 1:1). Next, the blots were incubated with an anti-NDUFS4monoclonal antibody (MS104, Mitosciences) for 4 h. Subsequently,
the blots were washed 3 times with 0.1% (w/v) Tween 20 containing
PBS (PBS-Tween) followed by incubation with the secondary anti-
body (IRDye 800CW Conjugated Goat Anti-mouse IgG (H+L), Highly
Cross Adsorbed; diluted 1:10,000; Li-Cor). Fluorescence scanning was
performed using an Odyssey Imaging system (Li-Cor) and ﬂuoro-
grams were inverted for visualization purposes.
2.7. SDS-PAGE analysis of glycolytic enzyme levels
Cells were grown in T175 ﬂasks, washed twice with PBS and
scraped off in 2 ml of cold isolation buffer (225 mM mannitol,
10 mM HEPES, 75 mM sucrose, 0.1 mM EGTA, pH 7.4, 1×) protease
inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany).
Cells were collected and centrifuged (10 min, 2000 g, 4 °C). The
resulting pellet was resuspended in cold isolation buffer and homog-
enized on ice with a 2 ml glass homogenizer. Subsequently the ho-
mogenate was centrifuged (5 min, 1000 g, 4 °C), the pellet was
discarded and the obtained supernatant was centrifuged (15 min,
15,000 g, 4 °C). The resulting supernatant and pellet were used as cy-
tosolic and mitochondrial fractions, respectively. The mitochondrial
fraction was then washed twice with cold washing buffer (395 mM
sucrose, 10 mM HEPES, 0.1 mM EGTA at pH 7.4) and centrifuged
(15 min, 15,000 g, 4 °C). Finally, the obtained pellet was resuspended
in 500 μl of washing buffer, frozen in liquid nitrogen and stored at
−80 °C. Exactly 25 μg of protein was loaded on a 10% SDS-PAGE gel.
Next, protein was transferred electrophoretically to a PVDF mem-
brane (Millipore) in transfer buffer. After blotting membranes were
blocked for 1 h with 5% (w/v) non-fat dried milk in 0.1% (w/v)
Tween 20 containing PBS (PBS-Tween). Afterward the blots were
rinsed twice with PBS-Tween and incubated over night at 4 °C with
polyclonal primary antibodies directed against HK-I (sc-6521, Santa
Cruz Biotech. Inc., Santa Cruz, USA), HK-II (sc-6519, Santa Cruz), P-
PDH pSer293 (Calbiochem, San Diego, USA), β-tubulin (E7, Develop-
mental Studies Hybridoma Bank, University of Iowa, Iowa City,
Iowa) or VDAC (the mitochondrial voltage dependent anion channel;
a.k.a. porin; Calbiochem, San Diego, USA). Subsequently, blots were
washed 3 times with PBS and incubated with secondary antibodies
anti-goat for HK-I and II and anti-rabbit for P-PDH. Fluorescence
was quantiﬁed using the Odyssey Imaging system described above
(Li-Cor).
2.8. Quantiﬁcation of routine oxygen consumption in intact cells
Cells were grown in DMEM containing 25 mM glucose and 4 mM
glutamine [32]. Routine (endogenous) respiration was measured
using 2 million cells in this DMEM medium, as described previously
[33] by monitoring oxygen consumption at 37 °C in a 1 ml, thermo-
statically controlled, chamber equipped with a Clark oxygen electrode
(Oxy 1, Hansatech, Pentney, UK).
2.9. Quantiﬁcation of routine, leak and maximal oxygen consumption in
intact cells
DMEM culture medium was collected and 1 million cells were
trypsinized, washed and resuspended in 60 μl of the collected culture
medium. Part of this suspension (50 μl) was used for cellular O2 con-
sumption analysis. O2 consumption was measured at 37 °C using po-
larographic oxygen sensors in a two-chamber Oxygraph (OROBOROS
Instruments, Innsbruck, Austria) using an established protocol [34].
2.10. Quantiﬁcation of cellular NAD+, NADH, NADP+ and NADPH levels
Determination of NAD+, NADH, NADP+ and NADPH levels was
performed in whole cell homogenates as described previously [35].
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and extracellular lactate concentration
Cells were seeded in 96-well plates and cell numbers were deter-
mined using Sulforhodamine B staining (SRB; Sigma). To this end,
cells were ﬁxed after 24, 48 and 72 h using trichloroacetic acid
(TCA) and 50 μl of 0.5% (v/v) SRB solution was added to each well.
After 30 min of incubation at room temperature the SRB solution
was removed and the cells were washed with acetic acid 1% (v/v)
and further incubated for 3 h at 60 °C to fully evaporate the acetic
acid. Next, 150 μl of 10 mM Tris was added to each well and absor-
bance was measured at 510 nm in a plate reader (Benchmark Plus,
Bio-rad). Glucose levels were determined by harvesting the culture
medium at 72 h and using the Amplex Red glucose/glucose oxidase
assay kit (Invitrogen). Lactate levels were determined by harvesting
the culture medium following 72 h of culturing and using the Amplex
Red glucose/glucose oxidase kit (Invitrogen) in which lactate oxidase
was used instead of glucose oxidase.
2.12. Quantiﬁcation of mitochondrial NAD(P)H autoﬂuorescence
MEFs were grown on glass coverslips (24 mm) to 70% conﬂuence.
Prior to imaging, the medium was replaced by a HEPES-Tris (HT) so-
lution containing 5.5 mM D-glucose (132 mM NaCl, 4.2 mM KCl,
1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES (pH 7.4)). For ﬂuores-
cence measurements, dishes were mounted in a thermostatic
(37 °C) superfusion chamber placed on the stage of an inverted mi-
croscope (Axiovert 200 M; Carl Zeiss, Jena, Germany) equipped with
a ×40, 1.3 NA F Fluar objective. NAD(P)H autoﬂuorescence was
detected using 360 nm excitation light delivered by a monochroma-
tor (Polychrome IV; TILL Photonics, Gräfelﬁng, Germany). Fluores-
cence light was directed by a 430DCLP dichroic mirror (Omega
Optical Inc., Brattleboro, USA) through a 510WB40 emission ﬁlter
(Omega) onto a CoolSNAP HQ monochrome CCD-camera (Roper Sci-
entiﬁc, Ottobrunn, Germany). The integration time of the CCD camera
was set at 1 s and hardware was controlled with Metaﬂuor 6.0 soft-
ware (MDS Analytical Technologies, Molecular Devices, Sunnyvale,
USA). The mean mitochondrial ﬂuorescence intensity was deter-
mined by placing a region of interest (ROI) in a mitochondria-dense
region of the cell. The intensity for this ROI was background corrected
using a nearby extracellular ROI [36,37].
2.13. Quantiﬁcation of total cellular ATP levels
ATP content was measured in lysed cells using the bioluminescent
ATP kit HS II (Roche Applied Science, Almere, The Netherlands). Cells
grown in DMEMmedium for 6 days were washed with PBS, detached
with trypsin and resuspended in fresh DMEM (100 μl of a cell suspen-
sion containing 2 million cells/ml). Subsequently cells were lysed to
release the intracellular ATP using the lysis buffer included in the
kit. 100 μl of the lysate was analyzed in a 96 well plate luminometer
(Luminoskan, Thermo Fisher Scientiﬁc, Breda, The Netherlands)
using the luciferine–luciferase reaction system provided in the kit.
100 μl of luciferine/ase was injected in the wells and after 10 s of in-
cubation the bioluminescent signal was quantiﬁed using an integra-
tion time of 1 s. Quantiﬁcation was performed by generating a
standard curve using ATP provided in the kit.
2.14. Quantiﬁcation of free cytosolic ATP levels
To visualize free cytosolic ATP levels, the ﬂuorescence resonance
energy transfer (FRET)-based reporter protein (‘ATeam’ 1.03) was
used. This sensor was composed of the ε subunit of the bacterial
FoF1-ATP synthase sandwiched between cyan-and yellow-
ﬂuorescent protein variants [38,39]. ATeam was expressed in the
cells using baculoviral transduction. To this end, a Bac-to-Bac systemnormally used for protein production in Spodoptera frugiperda insect
cells (Sf9) was made suitable for protein expression in mammalian
cells by cloning the vesicular stomatitis virus G protein cDNA behind
the P10 promoter of the pFastBacDual vector. Next, the CMV promot-
er and Gateway (Invitrogen) destination elements (i.e. a cassette con-
taining the chloramphenicol resistance gene and the ccdB gene
ﬂanked by attR1 and attR2 sites) were introduced in the pFastBacDual
vector [40]. The SpeI/HindIII fragment of human pcDNA3-ATeam-cyto
was ligated into the SpeI/HindIII sites of the pFastBacDual vector.
Baculoviruses were produced as described in the Bac-to-Bac manual
(Invitrogen). To express ATeam, cells were seeded on a WillCo-Dish
(22 mm; Intracel Ltd., Royston, UK) and cultured for 24 h. Cells
were then infected with the ATeam baculovirus (6% v/v) in HBSS buff-
er (Hank's Balanced Salt Solution 1×, Invitrogen) containing 0.25% v/v
of sodium butyrate (Sigma) and cultured for 6 h. Afterward the buffer
was removed and the cells were incubated with complete DMEMme-
dium for another 24 h. For ﬂuorescence measurements, dishes were
mounted in a thermostatic (37 °C) superfusion chamber placed on
the stage of an inverted microscope (Axiovert 200 M; Carl Zeiss)
equipped with a ×40, 1.3 NA F Fluar objective. During measurements
cells were maintained in HT medium. ATeam was excited at 435 nm
using a monochromator (TILL Photonics) and ﬂuorescence emission
light was directed by a 455DRLP dichroic mirror through either a
480AF30 (CFP-signal) or a 535AF26 emission ﬁlter (YFP-signal)
(Omega Optical Inc.) onto a CoolSNAP HQ monochrome CCD-
camera (Roper Scientiﬁc). The integration time of the CCD camera
was set at 200 ms and hardware was controlled with Metaﬂuor 6.0
software (MDS Analytical Technologies). Steady-state analysis was
performed by randomly measuring 10 ﬁelds of cells and calculating
the ratio between the background-corrected YFP and CPF ﬂuores-
cence signal for a cytosolic region of interest (ROI) in each individual
cell. Similarly, ATeam time-lapse analysis was carried out by acquir-
ing YFP and CFP images at an interval of 6 s. In the latter experiments
a superfusion system was used to replace the glucose-containing HT
medium by a HT medium in which the glucose was replaced by an
equimolar amount of the glycolysis inhibitor 2-deoxy-D-glucose (2-
DG; Sigma).
2.15. Quantiﬁcation of mitochondrial TMRM accumulation
Microscopy images of cells stained with 10 nM TMRM (tetra-
methyl rhodamine methyl ester; Invitrogen) were acquired using
the above microscopy system as described in detail before [41]. Dur-
ing measurements cells were maintained in HT medium. The mean
mitochondrial ﬂuorescence intensity was determined by drawing an
ROI in a mitochondria-dense perinuclear region of the cells. The in-
tensity for this ROI was background corrected using a nearby extra-
cellular ROI of identical size. Similarly, the background-corrected
nuclear TMRM intensity was determined using an ROI placed in the
nucleus [2].
2.16. Quantiﬁcation of reactive oxygen species levels
MEFs were grown on glass coverslips (24 mm) to 70% conﬂuence
and incubated in DMEM medium containing 10 μM hydroethidine
(HEt; Invitrogen) for exactly 10 min at 37 °C. HEt readily enters the
cell and can be oxidized to form two ﬂuorescent products: ethidium
(Et+) and 2-hydroxyethidium (2-OH-Et+). The reaction was stopped
by thoroughly washing the cells with PBS to remove excess HEt fol-
lowed by placing the cells in HT solution. Fluorescence images were
collected using the microscope system described above. During mea-
surements cells were maintained in HT medium. HEt oxidation prod-
ucts were visualized using a 490 nm excitation wavelength, a
525DRLP dichroic mirror (Omega) and a 565 ALP emission ﬁlter
(Omega). Routinely, 10 ﬁelds of view were analyzed per coverslip
using an acquisition time of 100 ms. The mean mitochondrial
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mitochondria-dense perinuclear region of the cells. The intensity for
this ROI was background corrected using a nearby extracellular ROI.
2.17. Image processing and data analysis
Image processing and analysis were performed using Metamorph
6.0 (MDS Analytical Technologies) and Image Pro Plus 6.1 software
(Media Cybernetics, Inc., Bethesda, MD, USA). Visualization of numer-
ical results, curve ﬁtting and statistical analysis was performed using
Origin Pro 6.1 software (OriginLab Corp., Northampton, MA, USA).
Unless stated otherwise, average data is presented as the mean±
SEM (standard error of the mean). Statistical differences were deter-
mined using either a two-population or one-population Student's t-
test (Bonferroni corrected).
3. Results
3.1. Mitochondria-enriched fractions from KO cells do not contain detect-
able amounts of NDUFS4 protein
Immortalized mouse embryonic ﬁbroblast (MEF) cell lines were
generated from two wildtype (wt) mouse embryos (wt1, wt2) and
two NDUFS4 KO mouse embryos (KO1, KO2). Genotyping conﬁrmedA
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KO2) MEF cell lines. Wt cells display a band at 1229 bp, whereas KO cells display a band at 42
NDUFS4 protein expression inmitochondrial fractions fromwt (wt1), KOs (KO1, KO2) and co
panel: a similar analysis comparing control (CT5120) and patient skin ﬁbroblasts carrying an
plasts fromwt and KOMEFs. (D) Similar to panel C but now for maximal CI activity. (E) Simila
CIII activity. (G) Similar to panel C but now for maximal SCC (succinate-cytochrome c reduc
panel C but now for maximal CIV activity. (I) Similar to panel C but now for maximal CV activ
ferent days. Statistical analysis was performed on the pooled data from wt (wt1+wt2) and
*(pb0.05), **(pb0.01) and ***(pb0.001). Abbreviations: n.s., not signiﬁcant; KO, NDUFS4 knthat the 800 bp fragment (corresponding to NDUFS4 gene) was ab-
sent in the KO cell lines (Fig. 1A). SDS-PAGE analysis of
mitochondria-enriched cell fractions demonstrated that NDUFS4 pro-
tein was absent in MEFs and muscle cells of the KO animal (Fig. 1B;
left and middle panels). Similar results were obtained in ﬁbroblasts
from patients with CI deﬁciency carrying an NDUFS4 mutation
(Fig. 1B; right panel; P5737, P5260). Reintroduction of the NDUFS4
gene in the KO cells led to reappearance of the NDUFS4 protein
(Fig. 1B; left panel; “KO1+S4”).3.2. NDUFS4 gene deletion reduces the maximal activity of CI, CII, CIII and
CIV but does not affect this parameter for CV and citrate synthase in
mitoplasts
Analysis of OXPHOS complex activity in mitoplasts under Vmax
conditions revealed that citrate synthase (CS) activity was not affect-
ed in KO cells (Fig. 1C), whereas CI activity was virtually undetectable
(Fig. 1D). NDUFS4 gene deletion also reduced the average maximal
activity of CII (by 18%; Fig. 1E), CIII (by 23%; Fig. 1F), combined
CII+CIII (“SCC”, by 44%; Fig. 1G) and CIV (by 25%; Fig. 1H). In con-
trast, the average CV activity was not affected (Fig. 1I). These results
demonstrate that NDUFS4 gene deletion greatly reduces maximal CI
activity and also lowers the activities of CII, CIII and CIV.D
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9 bp (the NDUFS4 subunit corresponds to 800 bp). (B) Left panel: SDS-PAGE analysis of
mplemented KOMEFs (KO1+S4). Middle panel: a similar analysis inmuscle cells. Right
NDUFS4 mutation (P5737, P5260). (C) Maximal citrate synthase (CS) activity in mito-
r to panel C but now for maximal CII activity. (F) Similar to panel C but now for maximal
tase) activity, a measure of the combined maximal activity of CII and CIII. (H) Similar to
ity. In this ﬁgure, numerals represent the number of assays performed on at least 2 dif-
KO cells (KO1+KO2). Signiﬁcant differences between wt and KO cells are marked by
ockout MEFs; S4, transfected with an NDUFS4-containing vector; wt, wildtype.
1930 F. Valsecchi et al. / Biochimica et Biophysica Acta 1817 (2012) 1925–19363.3. Mitochondria isolated from KO cells lack fully assembled CI on native
gels
Blue native (BN)-PAGE analysis (Fig. 2A) revealed that wt MEFS
expressed the fully-assembled 1000 kDa CI holocomplex (marked
“CI”). Instead of holo-CI, KO MEFs contained a CI subassembly of
smaller size (~830 kDa; marked “a”). NDUFS4 gene deletion did not
noticeably alter the levels of fully-assembled CII, CIII, CIV and CV. In-
gel activity (IGA) analysis demonstrated that the ~830 kDa CI subas-
sembly lacked CI activity (Fig. 2B; “KO1” and “KO2”). Reintroduction
of the NDUFS4 gene in the KO cells (“KO1+S4” and “KO2+S4”) led
to disappearance of the subassembly and reappearance of the fully as-
sembled CI and IGA signal. Complementation of wt cells did not affect
holo-CI expression and activity (“wt1+S4”). Similarly, expression of
an empty vector (“e”) in wt (“wt1+e”) and KO cells (“KO1+e” and
“KO2+e”) was without effect. These results demonstrate that dele-
tion of the NDUFS4 gene does not affect the expression of fully-
assembled CII, CIII, CIV and CV and is solely responsible for the altered
CI assembly pattern and absence of CI activity in the KO cells.
3.4. Mitochondria isolated from KO cells contain an active ~200 kDa CI
subassembly on native gels
We recently demonstrated the presence of an active ~200 kDa CI
subassembly in kidney, brain, liver, lung, heart and muscle tissue of
KO mice [42]. This subassembly, represents the NADH dehydrogenase
module of CI and at least contains the NDUFV1 and NDUFV2 subunits
of CI. Here we also detected the ~200 kDa CI subassembly in KO cells
(Fig. 2C, marked “b”), which disappeared on complementation with
the NDUFS4 subunit (“KO1+S4”).
3.5. Intact KO cells display a reduced oxygen consumption, which is fully
inhibited by the speciﬁc CI inhibitor rotenone
Given the reduced maximal activities of CI–CIV (Fig. 1), we next
investigated oxygen (O2) consumption in intact cells to obtain a mea-
sure of mitochondrial functional capacity. NDUFS4 gene deletion sig-
niﬁcantly reduced routine cellular O2 consumption (Fig. 3A). This
reduction was fully restored by NDUFS4 gene complementation
(“KO1+S4”). Acute application of the speciﬁc CI inhibitor rotenone
(ROT; 0.5 μM) directly inhibited cellular O2 consumption (Fig. 3B–
C). The latter was not reduced further by application of the CIII inhib-
itor antimycin A (AA; 2.5 μM; Fig. 3B–C). Cellular “leak” O2 consump-
tion (determined by application of the CV-inhibitor oligomycin (OLI;BA
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Fig. 2. BN-PAGE and in-gel activity analysis of wt and KO cells. (A) Arrows indicate the positi
enriched fractions, as detected using an antibody against the 39-kDa (NDUFA9) subunit of
(“CII-70”), CIII (“CIII-core2”), CIV (“CIV-2”) and CV (“CV-α”). (B) The top row is similar to t
of fully-assembled CII (using an antibody against the 70-kDa subunit of CII) serve as a loadi
depicts the in-gel activity (IGA) signal of CI, but now for a larger part of the gel. An active
(using an antibody against the 70-kDa subunit of CII) serve as a loading control (bottom ro
S4, transfected with an NDUFS4-containing vector; wt, wildtype MEFs.2.5 μM)) and minimal O2 consumption (determined by application of
OLI, the mitochondrial uncoupler FCCP (3.5 μM), ROT and AA) were
similar for KO and wt MEFs (Fig. 3D). Maximum cellular O2 consump-
tion (determined in the presence of OLI and FCCP) tended to be lower
in KO cells. These ﬁndings demonstrate that intact KO cells display a
substantial routine/maximal O2 consumption that is lower than that
in wt cells and completely and acutely blocked by ROT.
3.6. Total NAD+ is decreased and total NADH is increased in KO cell
homogenates
Previous live-cell microscopy analysis revealed that mitochondrial
NAD(P)H levels are increased in ﬁbroblasts from CI-deﬁcient patients
[16,37]. Here we observed that mitochondrial NAD(P)H autoﬂuores-
cence was also increased in living KO MEFs (Fig. 4A). Quantiﬁcation
of total NAD+, NADH, NADP+ and NADPH levels in whole cell homog-
enates revealed that the [NAD+] was reduced, whereas the [NADH]
was increased in KO cells (Fig. 4B). The latter was paralleled by a
slight increase in the levels of NADP+ and NADPH. The ratio between
the oxidized and reduced forms of nicotinamide adenine dinucleotide
([NAD+]/[NADH]) is an important component of the cellular redox
state. In KO cells, this ratio was ~2-fold lower (i.e. more reduced)
than in wt cells (Fig. 4C). In contrast, the ratio between [NADP+]
and [NADPH] was not affected in KO cells. These ﬁndings suggest
that CI-mediated NADH oxidation in KO cells is less efﬁcient than in
wt cells, inducing a reduction in [NAD+]/[NADH] ratio. In human
skin ﬁbroblasts, evidence was provided that an elevated cytosolic/mi-
tochondrial [NAD+]/[NADH] ratio is linked to increased extracellular
lactate levels [43]. Following 72 h of culturing, the culture medium
of KO cells contained more lactate than that of wt cells (Fig. 4D) but
a similar amount of glucose (Fig. 4E). In contrast to ﬁbroblasts from
CI-deﬁcient patients [44], oxidation of the reactive oxygen species
(ROS) reporter hydroethidine (HEt) was not increased in KO cells
(Fig. 4F). The latter suggests that NDUFS4 gene deletion does not in-
crease ROS levels.
3.7. KO cells display normal expression of hexokinase I/II and phosphor-
ylated pyruvate dehydrogenase
Although glucose levels were similar in the culture medium of wt
and KO MEFs, the reduced mitochondrial O2 consumption, the in-
creased [NAD+]/[NADH] ratio and the elevated lactate levels suggest
that glycolysis is enhanced in KO cells relative to wt cells [45,46]. The
mitochondrial association of hexokinase (HK) was demonstrated toC
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1931F. Valsecchi et al. / Biochimica et Biophysica Acta 1817 (2012) 1925–1936enhance the ﬂux through glycolysis [47]. However, Western blot
analysis revealed that the protein levels of HKI (Fig. 5A, E) and HK-II
(Fig. 5B, F) were not altered in KO cells, suggesting that NDUFS4
gene deletion does not up regulate the glycolysis pathway. Next, we
investigated the levels of phosphorylated pyruvate dehydrogenase
(P-PDH) in mitochondrial fractions. PDH phosphorylation decreases
the pyruvate ﬂux into the TCA cycle, which promotes pyruvate con-
version to lactate (i.e., aerobic glycolysis; [47]). Also the level of P-
PDH (Fig. 5C, G) was not affected by NDUFS4 gene deletion. Taken to-
gether, the results described in this paragraph suggest that NDUFS4
gene deletion does not trigger a major up regulation of glycolysis.
3.8. KO cells display normal total cellular and free cytosolic ATP levels
and a normal growth rate
Total cellular ATP content was not affected in KO cells (Fig. 6A).
Similarly, analysis of the free cytosolic [ATP] using the proteinaceous
ATP sensor “ATeam”, revealed no detectable differences (Fig. 6B). Also
the growth rate of the cells did not signiﬁcantly differ betweenwt andKO MEFs (Fig. 6C). When extracellular glucose was replaced by the
glycolysis inhibitor 2-deoxy-D-glucose (2-DG), which enters the cell
via the glucose transporters on the plasmamembrane, the free cyto-
solic [ATP] concentration decreased with a similar rate in KO and wt
cells (Fig. 6D, E, F). These ﬁndings demonstrate that the reduction in
ETC activity (Fig. 1) and O2 consumption (Fig. 3) does not detectably
disturb ATP homeostasis and cell growth. Moreover, the results
obtained with 2-DG suggest that the contribution of glycolysis-
derived ATP to the resting free cytosolic [ATP] is similar in wt and
KO cells. This supports our above conclusion that NDUFS4 gene dele-
tion does not trigger a major up regulation of glycolysis.
3.9. KO cells display increased mitochondrial TMRM ﬂuorescence that is
insensitive to oligomycin
The mitochondrial ﬂuorescence signal of the cation TMRM (tetra-
methyl rhodamine methyl ester) was slightly higher in KO cells than
in wt cells (Fig. 6G), suggesting hyperpolarization of the mitochondri-
al membrane potential (Δψ). The latter was not maintained by
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1932 F. Valsecchi et al. / Biochimica et Biophysica Acta 1817 (2012) 1925–1936reverse-mode action of mitochondrial CV (FoF1-ATPase), since incu-
bation of the cells with the CV-inhibitor oligomycin did not affect
the mitochondrial TMRM staining pattern (Fig. 6H; 48). QuantitativeBA
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1933F. Valsecchi et al. / Biochimica et Biophysica Acta 1817 (2012) 1925–1936slight mitochondrial hyperpolarization and that CV-reverse mode ac-
tion is absent in wt and KO MEFs.
4. Discussion
Isolated mitochondrial CI deﬁciency is one of the most common
OXPHOS deﬁciencies for which currently no cure is available[2,3,8,9,15]. Until recently, there was no good animal model for isolat-
ed human CI deﬁciency. Therefore, we and others used patient-
derived primary skin ﬁbroblasts for diagnostic, genetic and cell
(patho)biological analyses (e.g. [14,19,24,37,40,44,49–51]). Here we
determined the cell metabolic effects of NDUFS4 gene deletion by
comparing immortalized mouse embryonic ﬁbroblasts (MEFs) from
wildtype (wt) and NDUFS4−/− (KO) mice. These mice suffer from a
1934 F. Valsecchi et al. / Biochimica et Biophysica Acta 1817 (2012) 1925–1936progressive fatal encephalomyopathy and represent the ﬁrst animal
model for isolated CI deﬁciency in humans [25].
4.1. NDUFS4 gene deletion induces CI destabilization
Western blot analysis revealed that mitochondria-enriched frac-
tions from KO MEFs did not contain detectable amounts of
NDUFS4 protein. This is compatible with the fact that deletion of
exon 2 of the NDUFS4 gene precludes synthesis of mature NDUFS4
protein [25]. Analysis of mitoplast fractions demonstrated that
NDUFS4 gene deletion reduces the maximal activity (Vmax) of all
ETC complexes to a greater (CI) or lesser (CII–CIV) extent, whereas
CS and CV activities are not affected. Previous Vmax analysis in pa-
tient ﬁbroblasts with NDUFS4 mutations revealed a variety of results
including: (i) reduced CI activity and normal CIV activity [18], (ii)
reduced CI and reduced CIII activity [20], (iii) reduced CI and normal
CIII activity [52], (iv) reduced CI and reduced CIII [53], and (v) re-
duced CI, normal CIV and a slightly reduced CIII activity [54]. On na-
tive gels, fully-assembled CI was not detected and expression of
fully assembled CII, CIII, CIV and CV was normal in mitochondrial
fractions isolated from KO cells. Compatible with our result, it was
demonstrated previously that CIII stability is not affected by the ab-
sence of CI [55]. Our ﬁndings suggest that NDUFS4 gene deletion
greatly destabilizes CI and thereby also induces minor catalytic de-
fects in the other ETC complexes. The latter probably relates to the
observation that OXPHOS complexes are organized in supercom-
plexes that contain CI, CIII and CIV and possibly also CII [56]. In
this sense, the presence of the NDUFS4 protein and/or fully-
assembled CI might be required for activity regulation of CII–CIV
in intact cells.
In case of CI, native gel electrophoresis revealed that KOMEFs con-
tain two CI subassemblies with a size of ~830 kDa and ~200 kDa in-
stead of the fully-assembled complex (~1000 kDa). In-gel activity
analysis demonstrated that the ~200 kDa subassembly was active
whereas the ~830 kDa subassembly was not. Previous analysis of pri-
mary skin ﬁbroblasts from patients with an NDUFS4 mutation also
revealed an inactive ~830 kDa subcomplex [15,53]. However, in con-
trast to KOMEFs, mitoplast fractions of patient cells displayed consid-
erable CI activity (Vmax) in biochemical assays. This led us to propose
that the primary role of the NDUFS4 subunit is a regulatory one by
controlling the stability and, thus, the cellular expression of the active
complex [15], supporting a function for NDUFS4 in regulation of CI ac-
tivity [23,24]. In a parallel study, we recently analyzed the nature and
penetrance of the CI deﬁciency in primary tissues (pancreas, kidney,
liver, lung, brain, heart and muscle) from the KO animal [42]. This
analysis revealed that: (i) CI activity is reduced but not abolished by
NDUFS4 gene deletion, (ii) the diverse tissues contained both a
~830 kDa and an (active) ~200 kDa subassembly, (iii) the ~830 kDa
CI subassembly lacks the tip (i.e. the ~200 kDa subassembly) of CI,
and that this tip represents the NADH dehydrogenase module. We
proposed a model in which CIII stabilizes CI in the absence of
NDUFS4 to allow formation of active CI in the diverse tissues of the
KO animal [42].
Here we observed that routine and maximal O2 consumptions
were reduced in intact KO MEFs. Interestingly, respiration was imme-
diately and fully inhibited by acute application of the speciﬁc CI inhib-
itor rotenone. These results are compatible with the lower Vmax of the
ETC complexes and demonstrate that catalytically active CI is present
in the KO cells, supporting our above results obtained in KO mouse
tissues. The fact that oxygen consumption was completely inhibited
in rotenone-treated MEFs further suggests that CII-mediated succi-
nate oxidation is not of major importance in these cells. This might in-
dicate that succinate levels are low and/or the rotenone induced
increase in the level of mitochondrial NADH, a known inhibitor of
the TCA cycle, prevents succinate oxidation by CII (which also consti-
tutes part of the TCA cycle).Importantly, OXPHOS complexes display a tissue-dependent stoi-
chiometry, possibly affecting their (supercomplex-mediated) stabili-
ty [2]. Moreover, analysis of cell homogenates, mitochondria-
enriched fractions and mitoplasts requires the use of detergents
and/or permeabilization agents. Since these disrupt mitochondrial
structure and function, direct comparison with live-cell experiments
becomes difﬁcult [57]. Therefore the various CI activity values
obtained in the diverse cells and tissues (and perhaps also the activi-
ties of other ETC complexes), are subject to variations in ETC stoichi-
ometry and sample preparation, leading to different amounts of
functional enzyme due to CI instability, caused by the absence of
NDUFS4 [15,25,42]. This provides a potential explanation for the fact
that living KO cells display CI-dependent O2 consumption, whereas
fully-assembled and active CIs were not detected by native gel and
biochemical analysis.
4.2. NDUFS4 gene deletion elevates [NAD+]/[NADH] ratio and lactate
production
NDUFS4 KO cells displayed an increased mitochondrial NAD(P)
H autoﬂuorescence. A similar increase was previously observed
in patient-derived primary ﬁbroblasts carrying various NDUFS4
mutations [37,44,58]. Since autoﬂuorescence microscopy analysis
cannot discriminate between NADH and NADPH we also analyzed
whole cell homogenates and demonstrated that the cellular
[NAD+]/[NADH] ratio was increased whereas the [NADP+]/
[NADPH] ratio was normal in the KO cells. These results indicate
that CI malfunction is associated with increased cellular NADH
levels. Given the previously reported link between elevated cyto-
solic/mitochondrial [NAD+]/[NADH] ratio and extracellular lactate
levels [43], we also quantiﬁed lactic acid levels in the culture me-
dium. This revealed a 20% higher value in medium from KO cells,
following 72 h of culturing. Given the fact that the number of cells
was ~22% less and glucose levels were ~8% lower in KO cell cul-
tures, this suggests that KO cells are (slightly) more glycolytic
than wt cells.
4.3. NDUFS4 gene deletion does not induce a major switch toward a more
glycolytic cellular phenotype
Tumor cells known to be highly glycolytic, display increased ex-
pression of glycolytic enzymes, including hexokinases (HKs; [60]).
HKs catalyze the ﬁrst step of the glycolysis (i.e. the conversion of glu-
cose into glucose 6-phosphate; [39,47]). Similarly, upregulation of
aerobic glycolysis has been linked to inactivation of pyruvate dehy-
drogenase (PDH; [61]). PDH constitutes part of the pyruvate dehydro-
genase complex (PDC) located inside mitochondria and converts
pyruvate generated by the glycolysis into the TCA-cycle substrate
acetyl-CoA. Reversible phosphorylation of PDH acts as inhibitory
and decreases pyruvate ﬂux into the TCA cycle, which promotes pyru-
vate conversion to lactate [47]. PDH phosphorylation occurs at three
sites on the E1 alpha subunit of PDH (PDHE1α: Ser232, Ser293 and
Ser300) and phosphorylation at any one site leads to inhibition of
the complex in vitro [62]. Wt and KO MEFs displayed similar protein
levels of HK-I, HK-II and P-PDH. This argues against the idea that
NDUFS4 gene knockout triggers a major upregulation of the glycolytic
pathway in KO cells. However, spontaneously immortalized MEFs al-
ready display a high glycolytic activity that also appears to protect
from oxidative damage [59]. Moreover, spontaneous cell immortali-
zation has been associated with resistance to ROS-induced growth ar-
rest [63] and upregulation of oxidative stress pathway genes in
primary breast tumors [64]. This not only provides a plausible expla-
nation for the fact that oxidation of the ROS sensor hydroethidine
(HEt) was not increased in KO cells, but also suggests that a further
upregulation of glycolysis in NDUFS4 KO cells is unnecessary to sus-
tain cell function.
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solic ATP levels
Although routine O2 consumption was reduced in KO cells, total
cellular ATP content and free cytosolic [ATP] in resting cells were
not affected by NDUFS4 deletion. This suggests that the latter does
not detectably affect the balance between total cellular ATP produc-
tion and consumption. Cytosolic free [ATP] decayed at equal rates
when extracellular glucose was removed and replaced by the
glycolysis-inhibitor 2-DG. We conclude from this data that NDUFS4
gene deletion does not detectably alter the glycolysis-mediated ATP
generation pathway, further supporting our above conclusion that
NDUFS4 gene deletion does not upregulate glycolysis. CV inhibition
by oligomycin did not affect mitochondrial TMRM localization, argu-
ing against reverse-mode action of CV previously observed in glyco-
lytic cells [65] and cells with mtDNA mutations [48]. KO cells
displayed a mildly increased mitochondrial TMRM ﬂuorescence, sug-
gestive of Δψ hyperpolarization. A similar increase was observed in ﬁ-
broblasts from patients with a TMEM70 mutation, which displayed a
reduced expression and maximal activity of CV [66]. Δψ hyperpolari-
zation in glycolytic cells has been taken as evidence of reduced ATP
utilization [67]. This suggests that KO cell growth is slightly reduced
and glycolysis in the KO cells is slightly stimulated to compensate
for the loss in mitochondrial ATP producing capacity.
5. Conclusion
Taken together, our data support a mechanism in which NDUFS4
gene deletion induces CI destabilization leading to a reduction in
ETC function and mitochondrial O2 consumption. Given the metabolic
properties of immortalized MEFs (e.g. their high glycolytic rate), al-
terations in cell metabolism induced by mitochondrial dysfunction
might be difﬁcult to detect. This is illustrated by the (very) slight
shift toward a more glycolytic phenotype and our failure to demon-
strate increased ROS levels in the KO MEFs. In this sense, immortal-
ized cells and/or high-glucose culture conditions might not be ideal
to study the (patho)physiology of mitochondrial (dys)function. To
address this issue wt and KO MEFs, as well as primary cells, cultured
under low extracellular glucose or galactose conditions, are currently
analyzed in our laboratory.
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